|
The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
RECRUITINGPhase 4Sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital
Actively Recruiting
PhasePhase 4
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
Started2022-12-27
Est. completion2026-11-30
Eligibility
Age20 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05663242
Summary
This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary early lung cancer. The study will enroll approximately 300 volunteers to compare the progression-free or overall survival in patients undergoing video-assisted thoracoscopic surgery (VATS) for primary lung tumors between propofol and sevoflurane for the maintenance of anesthesia.
Eligibility
Age: 20 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: * eighteen to eighty-year-old * ASA class I-III patients * Received elective thoracic surgery for primary lung tumors under general anesthesia Exclusion Criteria: * mental disorder * poor liver function * pregnant or lactating women * morbidly obese * allergy to any of the drugs used in this study * recurrent tumor or repeat surgery * biopsy cases * incomplete outcome-data * palliative treatment after surgery * simultaneous treatment of other malignancies * emergency surgery * presence of other malignant tumors * combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine * diagnosed as benign lung tumor, or other metastatic lung tumor
Conditions4
AnesthesiaCancerLung CancerProgression, Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
Started2022-12-27
Est. completion2026-11-30
Eligibility
Age20 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05663242